CYP1B1 overexpression in various types of cancer has previously been reported to modify the biotransformation of chemotherapeutics, such as mitoxantrone, flutamide (FLUT), docetaxel (TXT), and PTX [56]. Here, CYP1B1 is linked to cancer.